{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:53:37Z","timestamp":1787756017791,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Cadherins (CDH), such as CDH11, are glycoprotein adhesion molecules contributing to cell-cell interactions in health and disease. CDH11 has demonstrated important functions in rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLS). In transcriptome expression studies, we observed that Cadherin 6 (CDH6) expression was higher in RA compared to osteoarthritis (OA). CDH6 is associated with cancer progression, but little information is known on the role of CDH6 in RA. The present study investigates CDH6 expression, regulation, function in FLS, and distribution in RA synovia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Synovial tissue and FLS were obtained from RA or OA patients undergoing joint replacement. CDH6 epigenetic marks and expression in RA and OA FLS were evaluated using public databases. CDH6 expression was determined by RT-PCR, Western blot, and immunostaining. RA and OA FLS were stimulated with cytokines and growth factors, and CDH6 mRNA expression was determined. CDH6 was silenced using siRNA, and the effect on migration, cell growth, apoptosis, autophagy, cell cycle, and signaling was studied.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>In our analysis of cadherin family expression, CDH6 expression was higher in RA than OA FLS. This was associated with differential chromatin accessibility and histone marks in the CDH6 promoter of RA FLS. H3K27ac was identified as an important regulator of CDH6 expression in RA FLS based on experiments using histone deacetylase inhibitors. TGF\u00df, but not IL-1\u03b2, TNF, IL-17A, IFN\u03b3, IL-6, or PDGF, increased CDH6 expression of cultured RA FLS. CDH6 knockdown significantly decreased RA FLS migration and cell growth. The latter was associated with increased apoptosis in CDH6 deficient FLS. Immunofluorescence showed CDH6 protein distribution in the membrane, perinuclear, and nuclear regions of cultured FLS. In RA synovial tissue, CDH6 expression was noted in FLS and macrophages within the lining and sublining regions.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>CDH6 expression is elevated in RA FLS due to epigenetic and local conditions of synovitis promoting migration, survival and cell growth, which are characteristic features of aggressive RA FLS. The intracellular distribution suggests additional functions beyond adhesion and homotypic aggregation, such as signaling and gene regulation. These data suggest CDH6 contributes to RA pathogenesis by influencing pathologic FLS behavior and could be a therapeutic target.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13075-025-03637-1","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T02:12:35Z","timestamp":1756433555000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Regulation of fibroblast-like synoviocyte function by cadherin 6 in rheumatoid arthritis"],"prefix":"10.1186","volume":"27","author":[{"given":"Camilla R. L.","family":"Machado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayanan B.","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Benschop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Dressler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Firestein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"1","key":"3637_CR1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233\u201355.","journal-title":"Immunol Rev"},{"issue":"6","key":"3637_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1056\/NEJMra2103726","volume":"388","author":"EM Gravallese","year":"2023","unstructured":"Gravallese EM, Firestein GS. Rheumatoid Arthritis \u2014 Common origins, divergent mechanisms. N Engl J Med. 2023;388(6):529\u201342.","journal-title":"N Engl J Med"},{"issue":"10","key":"3637_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41584-023-01015-2","volume":"19","author":"CRL Machado","year":"2023","unstructured":"Machado CRL, Firestein GS. Fibroblast multiplicity in RA: a synovial state of affairs. Nat Rev Rheumatol. 2023;19(10):609\u201310.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"3637_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrrheum.2012.190","volume":"9","author":"N Bottini","year":"2013","unstructured":"Bottini N, Firestein GS. Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors. Nat Rev Rheumatol. 2013;9(1):24\u201333.","journal-title":"Nat Rev Rheumatol"},{"issue":"13","key":"3637_CR5","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.3390\/ijms20133373","volume":"20","author":"JI Casal","year":"2019","unstructured":"Casal JI, Bartolom\u00e9 RA. Beyond N-cadherin, relevance of cadherins 5, 6 and 17 in cancer progression and metastasis. Int J Mol Sci. 2019;20(13):3373.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3637_CR6","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13075-015-0647-9","volume":"17","author":"EH Noss","year":"2015","unstructured":"Noss EH, Watts GFM, Zocco D, Keller TL, Whitman M, Blobel CP, et al. Evidence for cadherin-11 cleavage in the synovium and partial characterization of its mechanism. Arthritis Res Therapy. 2015;17(1):126.","journal-title":"Arthritis Res Therapy"},{"issue":"12","key":"3637_CR7","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1084\/jem.20041545","volume":"200","author":"X Valencia","year":"2004","unstructured":"Valencia X, Higgins JMG, Kiener HP, Lee DM, Podrebarac TA, Dascher CC, et al. Cadherin-11 provides specific cellular adhesion between fibroblast-like synoviocytes. J Exp Med. 2004;200(12):1673\u20139.","journal-title":"J Exp Med"},{"issue":"20","key":"3637_CR8","doi-asserted-by":"publisher","first-page":"8401","DOI":"10.1073\/pnas.1019437108","volume":"108","author":"SK Chang","year":"2011","unstructured":"Chang SK, Noss EH, Chen M, Gu Z, Townsend K, Grenha R, et al. Cadherin-11 regulates fibroblast inflammation. Proc Natl Acad Sci USA. 2011;108(20):8401\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"3637_CR9","doi-asserted-by":"publisher","first-page":"R626","DOI":"10.1016\/j.cub.2013.06.019","volume":"23","author":"JL Maitre","year":"2013","unstructured":"Maitre JL, Heisenberg CP. Three functions of cadherins in cell adhesion. Curr Biol. 2013;23(14):R626\u201333.","journal-title":"Curr Biol"},{"issue":"1","key":"3637_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-020-00340-2","volume":"5","author":"Y Kang","year":"2020","unstructured":"Kang Y, He W, Ren C, Qiao J, Guo Q, Hu J, et al. Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal Transduct Target Ther. 2020;5(1):245.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"3637_CR11","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/onc.2016.237","volume":"36","author":"M Gugnoni","year":"2017","unstructured":"Gugnoni M, Sancisi V, Gandolfi G, Manzotti G, Ragazzi M, Giordano D, et al. Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy. Oncogene. 2017;36(5):667\u201377.","journal-title":"Oncogene"},{"issue":"13","key":"3637_CR12","first-page":"2741","volume":"57","author":"R Paul","year":"1997","unstructured":"Paul R, Ewing CM, Robinson JC, Marshall FF, Johnson KR, Wheelock MJ, et al. Cadherin-6, a cell adhesion molecule specifically expressed in the proximal renal tubule and renal cell carcinoma. Cancer Res. 1997;57(13):2741\u20138.","journal-title":"Cancer Res"},{"issue":"1","key":"3637_CR13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12935-021-02071-y","volume":"21","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Li S, Li S, Wang J, Lin H, Fu W. High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer. Cancer Cell Int. 2021;21(1):493.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"3637_CR14","first-page":"1192","volume":"14","author":"A Park","year":"2024","unstructured":"Park A, Kim SE, Yu J, Son D, Kim KS, Koh E, et al. Cadherin-6 is a novel mediator for the migration of mesenchymal stem cells to glioblastoma cells in response to stromal cell\u2010derived factor\u20101. Federation Eur Biochem Soc Open Bio. 2024;14(7):1192\u2013204.","journal-title":"Federation Eur Biochem Soc Open Bio"},{"issue":"9","key":"3637_CR15","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1158\/2159-8290.CD-16-1414","volume":"7","author":"CU Bialucha","year":"2017","unstructured":"Bialucha CU, Collins SD, Li X, Saxena P, Zhang X, Durr C, et al. Discovery and optimization of HKT288, a cadherin-6-targeting ADC for the treatment of ovarian and renal cancers. Cancer Discov. 2017;7(9):1030\u201345.","journal-title":"Cancer Discov"},{"issue":"10","key":"3637_CR16","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1159\/000518549","volume":"44","author":"P Schoffski","year":"2021","unstructured":"Schoffski P, Concin N, Suarez C, Subbiah V, Ando Y, Ruan S, et al. A phase 1 study of a CDH6-Targeting antibody-drug conjugate in patients with advanced solid tumors with evaluation of inflammatory and neurological adverse events. Oncol Res Treat. 2021;44(10):547\u201356.","journal-title":"Oncol Res Treat"},{"issue":"9","key":"3637_CR17","first-page":"1580","volume":"69","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/european league against rheumatism collaborative initiative. Arthritis Rheum. 2010;69(9):1580\u20138.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"3637_CR18","first-page":"504","volume":"34","author":"R Altman","year":"1991","unstructured":"Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, et al. The American college of rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthr Rhuem. 1991;34(5):504\u201314.","journal-title":"Arthr Rhuem"},{"issue":"6","key":"3637_CR19","doi-asserted-by":"publisher","first-page":"e0304530","DOI":"10.1371\/journal.pone.0304530","volume":"19","author":"H Lee","year":"2024","unstructured":"Lee H, Machado CRL, Hammaker D, Choi E, Prideaux EB, Wang W, et al. Joint-specific regulation of homeobox D10 expression in rheumatoid arthritis fibroblast-like synoviocytes. PLoS ONE. 2024;19(6):e0304530\u2013e.","journal-title":"PLoS ONE"},{"issue":"1","key":"3637_CR20","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1038\/s41467-018-04310-9","volume":"9","author":"R Ai","year":"2018","unstructured":"Ai R, Laragione T, Hammaker D, Boyle DL, Wildberg A, Maeshima K, et al. Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes. Nat Commun. 2018;9(1):1921.","journal-title":"Nat Commun"},{"issue":"8","key":"3637_CR21","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/art.42856","volume":"76","author":"S Sendo","year":"2024","unstructured":"Sendo S, Machado CRL, Boyle DL, Benschop RJ, Perumal NB, Choi E, et al. Dysregulated NUB1 and neddylation enhances rheumatoid arthritis Fibroblast-Like synoviocyte inflammatory responses. Arthritis Rheumatol. 2024;76(8):1252\u201362.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"3637_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/acr2.11384","volume":"4","author":"C Ansalone","year":"2022","unstructured":"Ansalone C, Ainsworth RI, Nygaard G, Ai R, Prideaux EB, Hammaker D, et al. Caspase-8 variant G regulates rheumatoid arthritis Fibroblast-Like synoviocyte aggressive behavior. ACR Open Rheumatol. 2022;4(4):288\u201399.","journal-title":"ACR Open Rheumatol"},{"issue":"5","key":"3637_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1242\/dev.125.5.803","volume":"125","author":"EA Cho","year":"1998","unstructured":"Cho EA, Patterson LT, Brookhiser WT, Mah S, Kintner C, Dressler GR. Differential expression and function of cadherin-6 during renal epithelium development. Development. 1998;125(5):803\u201312.","journal-title":"Development"},{"issue":"12","key":"3637_CR24","doi-asserted-by":"publisher","first-page":"e179392","DOI":"10.1172\/jci.insight.179392","volume":"9","author":"E Choi","year":"2024","unstructured":"Choi E, Machado CRL, Okano T, Boyle D, Wang W, Firestein GS. Joint-specific rheumatoid arthritis fibroblast-like synoviocyte regulation identified by integration of chromatin access and transcriptional activity. JCI Insight. 2024;9(12):e179392.","journal-title":"JCI Insight"},{"issue":"6","key":"3637_CR25","doi-asserted-by":"publisher","first-page":"R157","DOI":"10.1186\/ar2052","volume":"8","author":"X You","year":"2006","unstructured":"You X, Boyle DL, Hammaker D, Firestein GS. PUMA-mediated apoptosis in fibroblast-like synoviocytes does not require p53. Arthritis Res Therapy. 2006;8(6):R157.","journal-title":"Arthritis Res Therapy"},{"issue":"9","key":"3637_CR26","doi-asserted-by":"publisher","first-page":"e75489","DOI":"10.1371\/journal.pone.0075489","volume":"8","author":"V Sancisi","year":"2013","unstructured":"Sancisi V, Gandolfi G, Ragazzi M, Nicoli D, Tamagnini I, Piana S, et al. Cadherin 6 is a new RUNX2 target in TGF-\u03b2 signalling pathway. PLoS ONE. 2013;8(9):e75489.","journal-title":"PLoS ONE"},{"issue":"6","key":"3637_CR27","doi-asserted-by":"publisher","first-page":"e157","DOI":"10.1038\/oncsis.2015.17","volume":"4","author":"YJ Su","year":"2015","unstructured":"Su YJ, Chang YW, Lin WH, Liang CL, Lee JL. An aberrant nuclear localization of E-cadherin is a potent inhibitor of Wnt\/\u03b2-catenin-elicited promotion of the cancer stem cell phenotype. Oncogenesis. 2015;4(6):e157\u2013e.","journal-title":"Oncogenesis"},{"issue":"9","key":"3637_CR28","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/jcmm.12340","volume":"18","author":"W Du","year":"2014","unstructured":"Du W, Liu X, Fan G, Zhao X, Sun Y, Wang T, et al. From cell membrane to the nucleus: an emerging role of E-cadherin in gene transcriptional regulation. J Cell Mol Med. 2014;18(9):1712\u20139.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"3637_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ncb3478","volume":"19","author":"A Labernadie","year":"2017","unstructured":"Labernadie A, Kato T, Brugues A, Serra-Picamal X, Derzsi S, Arwert E, et al. A mechanically active heterotypic E-cadherin\/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat Cell Biol. 2017;19(3):224\u201337.","journal-title":"Nat Cell Biol"},{"key":"3637_CR30","doi-asserted-by":"publisher","first-page":"949552","DOI":"10.3389\/fgene.2022.949552","volume":"13","author":"M Meng","year":"2022","unstructured":"Meng M, Zhou H, He Y, Chen L, Wang W, Yang L, et al. CDH6 as a prognostic indicator and marker for chemotherapy in gliomas. Front Genet. 2022;13:949552.","journal-title":"Front Genet"},{"issue":"7","key":"3637_CR31","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1002\/1878-0261.12947","volume":"15","author":"RA Bartolome","year":"2021","unstructured":"Bartolome RA, Robles J, Martin-Regalado A, Pintado-Berninches L, Burdiel M, Ja\u00e9n M, et al. CDH6-activated \u03b1IIb\u03b23 crosstalks with \u03b12\u03b21 to trigger cellular adhesion and invasion in metastatic ovarian and renal cancers. Mol Oncol. 2021;15(7):1849\u201365.","journal-title":"Mol Oncol"},{"issue":"6","key":"3637_CR32","first-page":"9498","volume":"15","author":"C Ma","year":"2018","unstructured":"Ma C, Zhao JZ, Lin RT, Zhou L, Chen YN, Yu LJ, et al. Combined overexpression of Cadherin 6, Cadherin 11 and cluster of differentiation 44 is associated with lymph node metastasis and poor prognosis in oral squamous cell carcinoma. Oncol Lett. 2018;15(6):9498\u201306.","journal-title":"Oncol Lett"},{"key":"3637_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbrc.2023.07.038","volume":"676","author":"GY Liu","year":"2023","unstructured":"Liu GY, Wang H, Ran R, Wang YC, Li Y. The GLI2\/CDH6 axis enhances migration, invasion and mitochondrial fission of stomach adenocarcinoma cells. Biochem Biophys Res Commun. 2023;676:182\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"9","key":"3637_CR34","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1242\/dev.02346","volume":"133","author":"MA Breau","year":"2006","unstructured":"Breau MA, Pietri T, Eder O, Blanche M, Brakebusch C, Fassler R, et al. Lack of \u03b21 integrins in enteric neural crest cells leads to a Hirschsprung-like phenotype. Development. 2006;133(9):1725\u201334.","journal-title":"Development"},{"issue":"7","key":"3637_CR35","doi-asserted-by":"publisher","first-page":"e11483","DOI":"10.1371\/journal.pone.0011483","volume":"5","author":"A Kalushkova","year":"2010","unstructured":"Kalushkova A, Fryknas M, Lemaire M, Fristedt C, Agarwal P, Eriksson M, et al. Polycomb target genes are silenced in multiple myeloma. PLoS ONE. 2010;5(7):e11483.","journal-title":"PLoS ONE"},{"issue":"1","key":"3637_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.coi.2006.11.008","volume":"19","author":"SM Wahl","year":"2007","unstructured":"Wahl SM. Transforming growth factor-beta: innately bipolar. Curr Opin Immunol. 2007;19(1):55\u201362.","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"3637_CR37","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.bbadis.2009.06.004","volume":"1792","author":"D Pohlers","year":"2009","unstructured":"Pohlers D, Brenmoehl J, Loffler I, Muller CK, Leipner C, Schultze-Mosgau S, Stallmach A, Kinne RW, Wolf G. TGF-beta and fibrosis in different organs - molecular pathway imprints. Biochim Biophys Acta. 2009;1792(8):746\u201356.","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"3637_CR38","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.ymthe.2018.03.009","volume":"26","author":"Q Ji","year":"2018","unstructured":"Ji Q, Xu X, Song Q, Xu Y, Tai Y, Goodman SB, et al. miR-223-3p inhibits human osteosarcoma metastasis and progression by directly targeting CDH6. Mol Ther. 2018;26(5):1299\u201312.","journal-title":"Mol Ther"},{"issue":"1","key":"3637_CR39","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/rth2.12458","volume":"5","author":"EG Bouck","year":"2021","unstructured":"Bouck EG, de la Fuente M, Zunica ER, Li W, Mumaw MM, Nieman MT. Murine cadherin-6 mediates thrombosis in vivo in a platelet-independent manner. Res Pract Thromb Haemost. 2021;5(1):125\u201331.","journal-title":"Res Pract Thromb Haemost"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03637-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-025-03637-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-025-03637-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T06:29:21Z","timestamp":1757485761000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-025-03637-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,29]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3637"],"URL":"https:\/\/doi.org\/10.1186\/s13075-025-03637-1","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,29]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by Human Research Protection Program, and all patients provided informed consent (Protocol #14\u20130175). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"172"}}